Considered together, these findings suggest that up-regulated expression of BCL3, SOCS3 and PIM1 in circulating CD4+ T cells of early RA patients is independent of potentially confounding clinical parameters, and accounts for much of the previously described 12-gene signature’s discriminatory ability for early RA. The gene discussed is CD4; the disease is rheumatoid arthritis.